Long-Term Outcomes Following Sirolimus-Coated Balloon or Drug-Eluting Stents for Treatment of In-Stent Restenosis.
Wojciech WańhaSylwia IwańczykRafal JanuszekRafał R WolnyBrunon TomasiewiczWiktor KuliczkowskiKrzysztof ReczuchPaweł PawlusTomasz Z PawłowskiLukasz KuzmaPiotr KublerPiotr NiezgodaPaul A GurbelRobert J GilTomasz F PawłowskiMariusz GąsiorMiłosz Jarosław JaguszewskiMaciej T WybraniecAdam WitkowskiMariusz KowalewskiFabrizio D'AscenzoAntonio GrecoStanisław BartuśMaciej LesiakMarek GrygierWojciech WojakowskiBernardo CortesePublished in: Circulation. Cardiovascular interventions (2024)
In patients with ISR, angioplasty with SCB compared with thin-struts DES is associated with comparable rates of target lesion revascularization, target vessel revascularization, myocardial infarction, all-cause death, and major adverse cardiovascular events at 2 years.